Neutralizing antibody levels rose 37-fold one month after the booster was given. Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within ...

Moderna said on Wednesday its bivalent Covid-19 vaccine booster that contained a vaccine targeting the Omicron variant showed a stronger immune response against the variant. Moderna said on Wednesday ...

Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday. COVID-19 vaccine makers are ...

Moderna’s updated COVID-19 shot, set to be deployed this fall, induced a “significant boost” of antibodies of the EG.5 omicron subvariant, nicknamed the Eris strain, according to preliminary clinical ...

Moderna shared this week that it has a new booster vaccine candidate that’s specifically targeted at Omicron variants of COVID-19. Moderna’s new Omicron booster contains Moderna’s original vaccine ...

Biotechnology company Moderna announced Monday that preliminary data suggests its half-dose booster shot increased antibody levels against Omicron compared with the levels seen when a fully vaccinated ...

Moderna reported on Dec. 20 that its currently authorized booster dose raises the level of antibodies able to neutralize the Omicron variant. The company performed preliminary tests to determine how ...

Shares of Moderna MRNA gained 9.3% on Jan 10, following the announcement that the company will proceed with the development of its mRNA-based Omicron-specific variant vaccine (mRNA-1273.529) to ...

Contractually remaining doses of Moderna's COVID-19 vaccine (Spikevax, mRNA-1273) will be converted to Moderna's next generation Omicron-containing bivalent vaccines Under the amendment, contractually ...

The CEO of Moderna warned on Tuesday that it will take months to develop a booster shot specific to the Omicron Covid variant despite President Joe Biden telling Americans they may need another jab to ...

Sept 12 (Reuters) - Canadian health officials on Tuesday authorized Moderna's (MRNA.O), opens new tab COVID-19 vaccine targeting the Omicron subvariant, urging all Canadians over the age of six months ...

Moderna’s updated COVID-19 vaccine for this fall provides a strong immune response to the BA.2.86 “Pirola” subvariant, according to new clinical data from the company. The updated COVID-19 vaccines ...